Bardoxolone Methyl Shown To Improve Renal Function in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

被引：0
|
作者：
Schwartz, Sherwyn L.
Denham, Douglas S.
Hurwitz, Craig A.
Meyer, Colin J.
Pergola, Pablo E.
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A30 / A30
页数：1
相关论文
共 50 条
  • [41] Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
    George Grunberger
    Sarah Camp
    Jeremy Johnson
    Susan Huyck
    Steven G. Terra
    James P. Mancuso
    Zhi Wei Jiang
    Gregory Golm
    Samuel S. Engel
    Brett Lauring
    Diabetes Therapy, 2018, 9 : 49 - 66
  • [42] INTERLEUKIN-18 AND RENAL ANEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND EARLY STAGES OF CHRONIC KIDNEY DISEASE
    Pchelin, Ivan
    Shishkin, Alexander
    Vasilkova, Volha
    Hudiakova, Natalia
    Kulibaba, Tatyana
    Slepykh, Liudmila
    Sheveleva, Marina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 219 - 220
  • [43] Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
    Grunberger, George
    Camp, Sarah
    Johnson, Jeremy
    Huyck, Susan
    Terra, Steven G.
    Mancuso, James P.
    Jiang, Zhi Wei
    Golm, Gregory
    Engel, Samuel S.
    Lauring, Brett
    DIABETES THERAPY, 2018, 9 (01) : 49 - 66
  • [44] The Endothelin Pathway: A Protective or Detrimental Target of Bardoxolone Methyl on Cardiac Function in Patients with Advanced Chronic Kidney Disease?
    Camer, Danielle
    Huang, Xu-Feng
    AMERICAN JOURNAL OF NEPHROLOGY, 2014, 40 (03) : 288 - 290
  • [45] Relationship Between Retinal Blood Flow and Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
    Nagaoka, Taiji
    Yoshida, Akitoshi
    DIABETES CARE, 2013, 36 (04) : 957 - 961
  • [46] Chronic kidney disease in patients with diabetes mellitus
    Nordheim, Espen
    Jenssen, Trond Geir
    ENDOCRINE CONNECTIONS, 2021, 10 (05) : R151 - R159
  • [47] EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE - POST-HOC ANALYSIS FROM BEAM AND BEACON
    Rossing, Peter
    Block, Geoffrey
    Chertow, Glenn
    Chin, Melanie
    Goldsberry, Angie
    McCullough, Peter
    Meyer, Colin
    Packham, David
    Spinowitz, Bruce
    Sprague, Stuart
    Warnock, David
    Pergola, Pablo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [48] MUSCLE INFARCTION AND SEVERE DETERIORATION OF RENAL FUNCTION IN A PATIENT WITH TYPE 1 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE
    Sanchez-Hernandez, R. M.
    Alberiche-Ruano, M. P.
    Lopez-Plasencia, Y.
    Marrero-Arencibia, D.
    Rodriguez-Perez, C. A.
    Novoa, F. J.
    Boronat, M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2016, 12 (02) : 224 - 226
  • [49] Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
    Berezina, Tetiana A.
    Obradovic, Zeljko
    Boxhammer, Elke
    Berezin, Alexander A. A.
    Lichtenauer, Michael
    Berezin, Alexander E. E.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [50] BARDOXOLONE METHYL PREVENTS EGFR DECLINE IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES - POST-HOC ANALYSES FROM BEACON
    Wanner, Christoph
    Bakris, George
    Block, Geoffrey
    Chin, Melanie
    Goldsberry, Angie
    Inker, Lesley
    Meyer, Colin
    O'Grady, Megan
    Pergola, Pablo
    Warnock, David
    Chertow, Glenn
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
12345